近期骨折患者就诊骨折联络服务时的体能表现与肌少症评估
这项横断面研究纳入1789例连续就诊于骨折联络服务(FLS)的近期骨折患者,评估椅立试验、握力、计时起走和6分钟步行试验及肌少症患病率,并与参考数据比较。各测试表现均偏低,髋部骨折、主要骨折或≥1处现存椎体骨折者Z评分更低,肌少症患病率为2.8%。
要点
- FLS患者椅立试验、握力、计时起走和6分钟步行试验功能受损/差的比例分别为39.2%、30.4%、21.9%和71.5%,期望比例为16%。
- 髋部骨折、主要骨折或≥1处现存椎体骨折患者上述测试Z评分更低(P<0.001)。
- 肌少症(按EWGSOP2)患病率为2.8%。
核心结论
- 与健康同龄人相比,FLS患者的体能表现显著较低,尤其是髋部骨折、主要骨折或现存椎体骨折患者。
- 这些发现强调需要评估和改善FLS患者的体能表现,尽管肌少症患病率较低。
研究设计与样本
- 横断面研究,纳入1789例连续就诊于骨折联络服务(FLS)的近期临床骨折患者,中位年龄66岁(IQR 59-74),女性占70.7%,骨折后3.9(±1.6)个月。
- 评估椅立试验(CST)、握力(HGS)、计时起走(TUG)、6分钟步行试验(6MWT)及肌少症(按EWGSOP2)。
- 计算与参考数据相比功能受损/差的比例(Z评分≥-2SD至<-1为受损,<-2SD为差),并用线性回归分析骨折类型、性别、年龄和骨折后时间与Z评分的关联。
主要发现
- CST、HGS、TUG和6MWT功能受损/差的比例分别为39.2%、30.4%、21.9%和71.5%(期望比例16%),肌少症患病率为2.8%。
- 髋部骨折、主要骨折和≥1处现存椎体骨折(VF)患者CST的Z评分较低(P<0.001):主要骨折回归系数B(95%CI)=-0.25[-0.34,-0.16];髋部骨折B=-0.32[-0.47,-0.17];VF B=-0.22[-0.34,-0.11]。
- 上述骨折类型患者TUG的Z评分较低(P<0.001):主要骨折B=-0.54[-0.75,-0.33];髋部骨折B=-1.72[-2.08,-1.35];VF B=-0.61[-0.88,-0.57]。
关键数值与推荐
- 肌少症诊断遵循EWGSOP2标准。
- 功能受损定义为Z评分≥-2SD至<-1,功能差定义为Z评分<-2SD。
- 参考数据的期望功能受损/差比例为16%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Impaired physical performance is associated with increased fracture risk. Performance on four physical functioning tests and prevalence of sarcopenia were assessed for 1789 fracture patients and compared to reference data. Performance was low on all tests, especially for patients with a hip, major or ≥ 1 prevalent vertebral fracture. PURPOSE INTRODUCTION: Impaired physical performance and sarcopenia are associated with increased fracture risk. This study aims to assess physical performance and the prevalence of sarcopenia in patients with a recent clinical fracture attending the Fracture Liaison Service (FLS) compared to population means. METHODS: In this cross-sectional study, chair stand test (CST), handgrip strength (HGS), timed-up-and-go (TUG), 6-min walking-test (6MWT), and sarcopenia (following EWGSOP2) were assessed. The proportion of patients with impaired/poor performance compared to reference data was calculated (Z-score: ≥ - 2SD to < - 1 (impaired) and < - 2 SD (poor)). Associations of fracture type, sex, age, and time since fracture with Z-scores were assessed using linear regression analyses. RESULTS: A total of 1789 consecutive FLS patients were included (median age (IQR): 66 (59-74), 70.7% females, 3.9 (± 1.6) months after fracture). The prevalence of impaired/poor performance for CST, HGS, TUG, and 6MWT was 39.2%, 30.4%, 21.9%, and 71.5%, respectively (expected proportion of 16%) and 2.8% had sarcopenia. Lower Z-scores (P < 0.001) were found for hip, major, and ≥ 1 prevalent vertebral fracture (VF) in CST (major: regression coefficient (B) (95%CI) = - 0.25 [- 0.34, - 0.16]; hip: B = - 0.32 [- 0.47, - 0.17], VF: B = - 0.22 [- 0.34, - 0.11]), TUG; (major: B = - 0.54 [- 0.75, - 0.33]; hip: B = - 1.72 [- 2.08, -1.35], VF: B = - 0.61 [- 0.88, - 0.57]), 6MWT (major: B = - 0.34 [- 0.47, - 0.21]; hip: B = - 0.99 [- 1,22, - 0.77], VF: B = - 0.36 [- 0.53, - 0.19]). CONCLUSIONS: Physical performance is significantly lower in FLS patients compared to healthy peers, especially in patients with hip, major or prevalent VF. These findings underline the need to assess and improve the physical performance of FLS patients, despite a low prevalence of sarcopenia.
引用
- Schene MR, Willems HC, Driessen JHM, et al. Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service. Osteoporos Int. 2024. PMID: 38349472. doi:10.1007/s00198-023-07009-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。